Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OPTIMA (Optimizing Prograf Therapy in Renal Transplant Patients)

Trial Profile

OPTIMA (Optimizing Prograf Therapy in Renal Transplant Patients)

Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2008

At a glance

  • Drugs Ciclosporin; Tacrolimus
  • Indications Renal transplant rejection; Transplant rejection
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms OPTIMA
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 22 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 25 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top